Versanis Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 21

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.93B

Versanis Bio General Information

Description

Developer of medicines designed to address medical conditions prevalent in older adults. The company offers treatment that induces loss of fat mass without loss of lean mass and improves cardiometabolic parameters, enabling overweight and obese adults to maintain healthy body composition.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1111 Broadway
  • Suite 1300
  • Oakland, CA 94607
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • 1111 Broadway
  • Suite 1300
  • Oakland, CA 94607
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Versanis Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 14-Aug-2023 $1.93B Completed Generating Revenue
1. Early Stage VC (Series A) 31-Aug-2021 Completed Clinical Trials - Phase 2
To view Versanis Bio’s complete valuation and funding history, request access »

Versanis Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Versanis Bio’s complete cap table history, request access »

Versanis Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medicines designed to address medical conditions prevalent in older adults. The company offers treatment th
Drug Discovery
Oakland, CA
21 As of 2023

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Versanis Bio Competitors (1)

One of Versanis Bio’s competitors is ERX Pharmaceuticals, a Corporation company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ERX Pharmaceuticals Corporation Cambridge, MA
You’re viewing 1 of 1 competitors. Get the full list »

Versanis Bio Patents

Versanis Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025227988-A1 Actrii antibodies with extended half life Pending 28-Feb-2024
WO-2025183966-A1 Actrii antibodies with extended half life Pending 28-Feb-2024
JP-2025529933-A Actrii antibody fixed unit dose treatment Pending 26-Aug-2022
AU-2023329487-A1 Actrii antibody fixed unit dose treatments Pending 26-Aug-2022
EP-4577301-A1 Actrii antibody fixed unit dose treatments Pending 26-Aug-2022 C07K16/2863
To view Versanis Bio’s complete patent history, request access »

Versanis Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Versanis Bio Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aditum Bio Venture Capital Minority
Atlas Venture Venture Capital Minority
Forbion Venture Capital Minority
Medicxi Ventures (UK) Venture Capital Minority
TCG Crossover Management Venture Capital Minority
To view Versanis Bio’s complete investors history, request access »

Versanis Bio FAQs

  • When was Versanis Bio founded?

    Versanis Bio was founded in 2020.

  • Where is Versanis Bio headquartered?

    Versanis Bio is headquartered in Oakland, CA.

  • What is the size of Versanis Bio?

    Versanis Bio has 21 total employees.

  • What industry is Versanis Bio in?

    Versanis Bio’s primary industry is Drug Discovery.

  • Is Versanis Bio a private or public company?

    Versanis Bio is a Private company.

  • What is the current valuation of Versanis Bio?

    The current valuation of Versanis Bio is .

  • What is Versanis Bio’s current revenue?

    The current revenue for Versanis Bio is .

  • How much funding has Versanis Bio raised over time?

    Versanis Bio has raised $70M.

  • Who are Versanis Bio’s investors?

    Aditum Bio, Atlas Venture, Forbion, Medicxi Ventures (UK), and TCG Crossover Management have invested in Versanis Bio.

  • Who are Versanis Bio’s competitors?

    ERX Pharmaceuticals is a competitor of Versanis Bio.

  • When was Versanis Bio acquired?

    Versanis Bio was acquired on 14-Aug-2023.

  • Who acquired Versanis Bio?

    Versanis Bio was acquired by Lilly USA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process